Epigenomics AG (LON:0QXH)
London · Delayed Price · Currency is GBP · Price in EUR 0.8820
-0.0080 (-0.90%)
At close: Nov 14, 2025
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of 672.26 thousand as of February 12, 2026. Its market cap has decreased by -26.52% in one year.
Market Cap
672.26K
Enterprise Value
9.92M
Revenue
3.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 40.84M to 672.26K, a decrease of -98.35%. That is a compound annual growth rate of -30.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 663.48K | -3.72% |
| Dec 30, 2025 | 689.10K | -15.21% |
| Dec 30, 2024 | 812.70K | -40.99% |
| Dec 29, 2023 | 1.38M | -77.01% |
| Dec 30, 2022 | 5.99M | -12.75% |
| Dec 30, 2021 | 6.87M | -60.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Worldsec | 1.06M |
| Wolfram Resources | 984.00K |
| Everest Global | 967.36K |
| Associated British Engineering | 819.60K |
| Pristine Capital | 723.26K |
| Ashington Innovation | 635.23K |
| Medcaw Investments | 608.63K |
| Acceler8 Ventures | 600.00K |